標普和納斯達克內在價值 聯繫我們

Quest Diagnostics Incorporated DGX NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
55/100
1/7 Pass
SharesGrow Intrinsic Value
$305.38
+57.3%
Analyst Price Target
$215.10
+10.8%

Quest Diagnostics Incorporated (DGX) 是一家上市公司 屬於 醫療保健 板塊,經營於 Medical - Diagnostics & Research 產業. 公司總部位於 Secaucus, NJ, 美国. 現任CEO為 James E. Davis.

DGX 擁有 IPO日期為 1996-12-17, 55,000 名全職員工, 在 NYSE, 市值為 $21.49B.

關於 Quest Diagnostics Incorporated

Quest Diagnostics Incorporated is a leading provider of diagnostic testing, information, and services operating in the United States and internationally. The company delivers a comprehensive range of clinical laboratory services, including routine testing, advanced clinical testing, and anatomic pathology testing, serving patients, clinicians, hospitals, health plans, and employers through an extensive network of laboratories and patient service centers. Quest Diagnostics operates multiple diagnostic brands including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, while also offering risk assessment services for the life insurance industry and healthcare information technology solutions to support clinical operations. Founded in 1967 and headquartered in Secaucus, New Jersey, the company leverages a diverse workforce of phlebotomists, nurses, and health professionals to deliver diagnostic information across multiple service channels.

📍 500 Plaza Drive, Secaucus, NJ 07094 📞 973 520 2700
公司詳情
所屬板塊醫療保健
細分行業Medical - Diagnostics & Research
國家美国
交易所NYSE
貨幣USD
IPO日期1996-12-17
首席執行官James E. Davis
員工數55,000
交易資訊
當前價格$194.16
市値$21.49B
52週區間157.2-213.5
Beta0.65
ETF
ADR
CUSIP74834L100
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值,發現被低估的股票。
每週線上課程
給我們留言